- Home
- HUBC vs PHGE Comparison
HUBC vs PHGE Comparison
Compare HUBC & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBC
- PHGE
- Stock Information
- Founded
- HUBC 2017
- PHGE 2015
- Country
- HUBC Israel
- PHGE Israel
- Employees
- HUBC N/A
- PHGE N/A
- Industry
- HUBC
- PHGE Biotechnology: Pharmaceutical Preparations
- Sector
- HUBC
- PHGE Health Care
- Exchange
- HUBC Nasdaq
- PHGE Nasdaq
- Market Cap
- HUBC N/A
- PHGE 13.3M
- IPO Year
- HUBC N/A
- PHGE N/A
- Fundamental
- Price
- HUBC $3.09
- PHGE $0.58
- Analyst Decision
- HUBC
- PHGE Strong Buy
- Analyst Count
- HUBC 0
- PHGE 2
- Target Price
- HUBC N/A
- PHGE $23.00
- AVG Volume (30 Days)
- HUBC 172.9K
- PHGE 181.1K
- Earning Date
- HUBC 12-13-2024
- PHGE 05-19-2025
- Dividend Yield
- HUBC N/A
- PHGE N/A
- EPS Growth
- HUBC N/A
- PHGE N/A
- EPS
- HUBC N/A
- PHGE N/A
- Revenue
- HUBC $33,357,000.00
- PHGE N/A
- Revenue This Year
- HUBC N/A
- PHGE N/A
- Revenue Next Year
- HUBC N/A
- PHGE N/A
- P/E Ratio
- HUBC N/A
- PHGE N/A
- Revenue Growth
- HUBC N/A
- PHGE N/A
- 52 Week Low
- HUBC $2.65
- PHGE $0.48
- 52 Week High
- HUBC $21.70
- PHGE $4.99
- Technical
- Relative Strength Index (RSI)
- HUBC 34.90
- PHGE 45.44
- Support Level
- HUBC $2.65
- PHGE $0.48
- Resistance Level
- HUBC $3.72
- PHGE $0.70
- Average True Range (ATR)
- HUBC 0.69
- PHGE 0.07
- MACD
- HUBC -0.10
- PHGE 0.01
- Stochastic Oscillator
- HUBC 12.01
- PHGE 46.19
Stock Price Comparison Chart: HUBC vs PHGE
■ HUBC
■ PHGE
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
Share on Social Networks:
0